1. Buy Adipotide OXY-ADI Peptide (10 mg) OxyPharma: Adipotide is an investigational peptide studied for its effect on adipose tissue and weight loss. Its action centres on the vasculature of fat tissue, which can help reduce the volume of fat deposits. Most commonly, Adipotide features in “cutting” programmes, body-sculpting routines, and strategies to lower subcutaneous fat percentage. It is not a substitute for diet and physical activity — results hinge on the wider nutrition and training load. 2. Recommended dosages and dosage regimens: Protocols are selected individually, based on goals, body weight and tolerance. In research practice, short courses with step-by-step assessment of the body’s reaction are more common. Starting low and building up is the sensible route. Blood pressure, general wellbeing and metabolic markers should be tracked during use. 3. What can be combined with: AOD-9604 or HGH Frag (176-191) — to reinforce the fat-burning effect. MOTS-c — to back up metabolism and energy pathways. L-carnitine, omega-3, coenzyme Q10 — as baseline support for weight loss. Nutrition, calorie deficit and cardio remain the primary focus. 4. Duration of the course: Short courses are the standard — 2–4 weeks. A break follows, then an assessment of the result. Repeat courses are reasonable only after reviewing how the body responded. Effectiveness is best read through body measurements and weight dynamics. Peptides, Adipotide OXY-ADI (10 mg) OxyPharma
Adipotide OXY-ADI peptide (10 mg) OxyPharma
€0.00
1. Adipotide OXY-ADI Peptide (10 mg) OxyPharma — overview
Adipotide is an investigational peptide examined in the context of its action on adipose tissue and weight reduction. It is associated with an effect on the vasculature of adipose tissue — which may contribute to a reduction in fat volume. Most of its use sits in “cutting” programmes, figure correction and lowering the subcutaneous fat percentage. It doesn’t replace diet or physical activity; the outcome depends on the overall nutritional plan and training load.
2. Recommended dosages and regimens
Protocols are selected individually based on goals, body weight and tolerance. Research practice tends to favour short courses with ongoing assessment of the body’s response. Starting with the lowest effective load — and gradually gauging the body’s reaction — is the sensible path. Across the course, monitoring of general condition, blood pressure and metabolic markers matters.
3. What Adipotide combines with
AOD-9604 or HGH Frag (176-191) — to reinforce the fat-burning effect.
MOTS-c — to support metabolism and energy flow.
L-carnitine, omega-3, coenzyme Q10 — as baseline support for weight loss.
The primary focus remains nutrition, calorie deficit and cardio.
4. Course duration
Courses are typically short — 2 to 4 weeks. A break follows completion for assessment of results. Repeat courses only make sense once the body’s reaction has been reviewed. Effectiveness is best gauged through body measurements and weight dynamics.
Peptides, Adipotide OXY-ADI (10 mg) OxyPharma
Out of stock
Adipotide (FTPP) is an experimental peptide — a pro-apoptotic agent targeting the vasculature of white adipose tissue specifically. Preclinical work shows marked fat mass reduction in primate models; human data remains limited. Protocols cited in community use run 0.5–1 mg daily sub-cut for 10 to 28 days. Reconstitute the 10 mg vial with 2 ml bacteriostatic water for a 5 mg/ml working concentration. Renal workload is a published concern, so hydration and kidney panels before and after are more or less the sensible floor.
| Peptide | Adipotide (FTPP) |
| Vial content | 10 mg lyophilised |
| Manufacturer | OxyPharma |
| Form | Freeze-dried peptide for subcutaneous use |
| Purpose | Experimental fat-loss agent targeting adipose vasculature |
| Reconstitution | Bacteriostatic water, 2 ml |
| Storage before mixing | Below 25 °C in a dry place |
| Storage after mixing | 2–8 °C |
Adipotide (also known as FTPP) is a research-stage peptide designed to selectively kill adipose-tissue vasculature. 10 mg vial, lyophilised for sub-cut delivery.
Doses are strictly experimental: short four-week courses at around 0.3 mg/kg are the published protocol. The peptide induces apoptosis in fat-cell blood supply, causing targeted fat loss — most commonly abdominal. Still a research compound; renal effects noted in trials warrant caution.
Frequently Asked Questions
What is Adipotide designed to do?
Adipotide is an experimental peptide designed to disrupt blood supply to fat cells. It has only been tested in animal models and remains outside clinical use.
What does Adipotide target in the body?
Adipotide targets the vasculature feeding white adipose tissue. Without a blood supply, fat cells die off — in theory, at least.
How long is a safe course of Adipotide?
The usual dosing is experimental dose — commonly 0.5 mg per kg, kept up for three to four weeks maximum.
Can Adipotide be stacked with other peptides?
Adipotide remains experimental, so protocols vary widely. Short runs are typical and the compound targets the vasculature feeding white adipose tissue.
What mechanism does Adipotide use for fat loss?
Adipotide targets the blood vessels feeding white adipose tissue, cutting off their supply and triggering apoptosis in nearby fat cells.
Reviews
There are no reviews yet